RANUSPET

Description

Colombia Reg. ICA N°: 10252-MV

1. GUARANTEED COMPOSITION:

Each 1 mL of oral solution contains:
Ranitidine base 5.50 mg
(As Ranitidine hydrochloride 6.14 mg)
Excipients q.s. to 1 mL

2. INDICATIONS:

Indicated as an adjuvant in the treatment of conditions associated with gastric acid hypersecretion.

3. SPECIES FOR WHICH IT IS RECOMMENDED:

Dogs and cats.

4. ROUTE OF ADMINISTRATION:

Oral use only.

5. DOSAGE:

• In dogs and cats, administer orally 2 – 4 mg/kg of body weight.
• In practice, administer 2 – 4 mL of the product per 5 kg of body weight, 2 – 3 times a day.

6. PRECAUTIONS:

• Administer orally only.
• Use with caution in patients with renal disorders or impairment.
• In long-term treatments or at high doses, monitor serum ALT levels.
• Use with caution in pregnant and lactating females.
• Store at a temperature below 30 ºC, protected from light.

CONTRAINDICATIONS:

Do not administer to patients with hypersensitivity to the active ingredient.

7. MANDATORY STATEMENTS:

• Keep out of reach of children and domestic animals.
• Sale by prescription of a Veterinarian.
• Consult your Veterinarian.
• The final disposal of empty containers or those with residual content must be carried out according to current environmental regulations.
• Veterinary use.

8. PRESENTATIONS:

Registered: Bottle of 30, 60 and 120 mL.